Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNN4 | O15554 | 3/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.41 |
| ▸ | MAOA | P21397 | 1/20 | 0.41 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.41 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.41 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.41 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.41 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.39 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17077295 | 0.82 | ADRA2A (0.43) | KCNN4CYP2D6CYP1A2TAAR1SLC6A2 | |
| SCHEMBL28351447 | 0.82 | CYP1A2 (0.42) | KCNN4CYP2D6CYP1A2TAAR1SLC6A2 | |
| SCHEMBL28351446 | 0.82 | CYP1A2 (0.42) | KCNN4CYP2D6CYP1A2TAAR1SLC6A2 | |
| Ammonia Solution, Strong SCHEMBL1484878 | 0.80 | CYP1A2 (0.41) | KCNN4CYP2D6CYP1A2TAAR1SLC6A2 | |
| SCHEMBL1701240 | 0.80 | KCNN4 (0.53) | KCNN4CYP2D6CYP1A2TAAR1SLC6A2 | |
| SCHEMBL5696040 | 0.78 | KCNN4 (0.42) | KCNN4CYP2D6CYP1A2TAAR1MAPK1 | |
| SCHEMBL22402881 | 0.78 | CYP2D6 (0.46) | KCNN4CYP2D6CYP1A2TAAR1HIF1A | |
| SCHEMBL11772011 | 0.78 | KCNN4 (0.48) | KCNN4CYP2D6CYP1A2TAAR1LMNA | |
| SCHEMBL20999978 | 0.77 | TAAR1 (0.44) | KCNN4CYP2D6CYP1A2TAAR1SLC6A2 | |
| SCHEMBL114847 | 0.77 | KCNN4 (0.48) | KCNN4CYP2D6CYP1A2TAAR1SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024112201-A1 | DNA GYRASE INHIBITORS | UNIVERSITEIT LEIDEN (NL) | 2024-05-30 | — | — | WO | disclosed |
| US-7408023-B2 | Peptoids incorporating chemoselective functionalities | NOVARTIS VACCINES AND DIAGNOSTICS, INC. (US) | 2008-08-05 | — | — | US | disclosed |
| US-20060188916-A1 | Peptoids incorporating chemoselective functionalities | NOVARTIS VACCINES AND DIAGNOSTICS, INC. | 2006-08-24 | — | — | US | disclosed |
| US-7030216-B2 | Peptoids incorporating chemoselective functionalities | CHIRON CORPORATION (US) | 2006-04-18 | — | — | US | disclosed |
| US-20020169281-A1 | Peptoids incorporating chemoselective functionalities | CHIRON CORPORATION | 2002-11-14 | — | — | US | disclosed |
| WO-2002081637-A2 | PEPTIDES INCORPORATING CHEMOSELECTIVE FUNCTIONALITIES | CHIRON CORPORATION (US) | 2002-10-17 | — | — | WO | disclosed |
| EP-0087709-A1 | N,N',N\"-triaryl-1,2,3-triaminopropane derivatives, process for their preparation and their use as intermediates | HOECHST AKTIENGESELLSCHAFT (DE) | 1983-09-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060188916-A1 | Peptoids incorporating chemoselective functionalities | VIP, PCNA, DNPEP | KCNN4 4438/4885CYP2D6 3499/4885CYP1A2 4586/4885 |
| US-20020169281-A1 | Peptoids incorporating chemoselective functionalities | VIP, PCNA, DNPEP | KCNN4 4438/4885CYP2D6 3499/4885CYP1A2 4586/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.